Prasanti Kotta

Dr. Prasanti Kotta

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
PKPrasanti Kotta
Prasanti Kotta
MEMadhivanan Elango
Madhivanan Elango
Vassilios PapaloisVassilios Papalois
Vassilios Papalois
Patients with end-stage kidney disease (ESKD) have a high prevalence of cardiovascular disease; it is the leading cause of death in these patients and the optimisation of their cardiovascular health may improve their post-transplant outcomes. Patients awaiting renal transplant often spend significant amounts of time on the waiting list allowing for the assessment and optimisation of their cardiovascular system. Coronary artery disease (CAD) is commonly seen in these patients and we explore the possible functional and anatomical investigations that can help assess and manage CAD in renal transplant candidates. We also discuss other aspects of cardiovascular assessment and management including arrhythmias, impaired ventricular function, valvular disease, lifestyle and pulmonary arterial hypertension. We hope that this review can form a basis for centres hoping to implement an enhanced recovery after surgery (ERAS) protocol for renal transplantation.

21 December 2023 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
MRMichael Randazzo
Michael Randazzo
FMFrancesco Maffessanti
Francesco Maffessanti
PKPrasanti Kotta
Prasanti Kotta
JGJulia Grapsa
Julia Grapsa
RLRoberto M. Lang
Roberto M. Lang
KAKarima Addetia
Karima Addetia
Recent inroads into percutaneous-based options for the treatment of tricuspid valve disease has brought to light how little we know about the behavior of the right ventricle in both health and disease and how incomplete our assessment of right ventricular (RV) physiology and function is using current non-invasive technology, in particular echocardiography. The purpose of this review is to provide an overview of what three-dimensional echocardiography (3DE) can offer currently to enhance RV evaluation and what the future may hold if we continue to improve the 3D evaluation of the right heart.

Verified
Journal Article
Open access
PDF file
PKPrasanti Kotta
Prasanti Kotta
VNVijay Nambi
Vijay Nambi
BBBiykem Bozkurt
Biykem Bozkurt
Heart failure (HF) is a global pandemic affecting over 64 million people worldwide. Its prevalence is on an upward trajectory, with associated increasing healthcare expenditure. Organizations including the American College of Cardiology (ACC) and the American Heart Association (AHA) have identified HF prevention as an important focus. Recently, the ACC/AHA/Heart Failure Society of America (HFSA) Guidelines on heart failure were updated with a new Class IIa, Level of Evidence B recommendation for biomarker-based screening in patients at risk of developing heart failure. In this review, we evaluate the studies that have assessed the various roles and contributions of biomarkers in the prediction and prevention of heart failure. We examined studies that have utilized biomarkers to detect cardiac dysfunction or abnormality for HF risk prediction and screening before patients develop clinical signs and symptoms of HF. We also included studies with biomarkers on prognostication and risk prediction over and above existing HF risk prediction models and studies that address the utility of changes in biomarkers over time for HF risk. We discuss studies of biomarkers to guide management and assess the efficacy of prevention strategies and multi-biomarker and multimodality approaches to improve risk prediction.

1 September 2021 in Clinical Medicine
Verified
Journal Article
Open access
PDF file
PKPrasanti Kotta
Prasanti Kotta
MEMadhivanan Elango
Madhivanan Elango
NMNitya Matcha
Nitya Matcha
KCKatarina Yk Chow
Katarina Yk Chow
The foundation programme is a 2-year training programme for newly qualified doctors and aims to bridge the gap between medical school and specialty training. The pandemic led to some major disruptions to foundation training. As foundation trainees, we encountered new challenges: there were reduced learning opportunities and our future paths became uncertain with changes to specialty training applications and membership exams. However, it is said that every crisis creates new opportunities and is a test of our resilience and innovativeness. There was the adoption of novel teaching methods, new research opportunities, increased importance given to teamwork and support for our wellbeing and mental health. We learnt lessons from this crisis that we should take forward to improve foundation training for the future.

19 February 2024 in Heart Rhythm
Verified
Journal Article
Closed access
PKPrasanti Kotta
Prasanti Kotta
VNVijay Nambi
Vijay Nambi
AMArunima Misra
Arunima Misra
HAHamid Afshar
Hamid Afshar
MCMihail G. Chelu
Mihail G. Chelu
AMAbdul Mannan Khan Minhas
Abdul Mannan Khan Minhas

7 July 2025 in Cardiovascular Drugs and Therapy
Verified
Journal Article
Closed access
PDF file
PKPrasanti Kotta
Prasanti Kotta
LULakshmi Uppalapati
Lakshmi Uppalapati
MEMadhivanan Elango
Madhivanan Elango
JTJeffrey Triska
Jeffrey Triska
MSMourad H. Senussi
Mourad H. Senussi